Respiratory syncytial virus prevents the subsequent development of ovalbumin-induced allergic responses by inhibiting ILC2 via the IL-33/ST2 pathway

Immunotherapy

Volumn 10, Issue 12, 2018, Pages 1065-1076

  Wang, Dandan ^a   Bai, Song ^a   Cui, Yulin ^a   Zhao, Na ^a   Qi, Feifei ^a   Liu, Jing ^a   Zeng, Sheng ^a   Xu, Lei ^a   Hu, Haiyan ^a   Liu, Beixing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

allergic airway inflammation; group 2 innate lymphoid cell; IL 33 ST2; ILC2; respiratory syncytial virus; RSV

Indexed keywords

INTERLEUKIN 1 RECEPTOR LIKE 1 PROTEIN; INTERLEUKIN 33; ALLERGEN; IL1RL1 PROTEIN, HUMAN; OVALBUMIN;

ADOPTIVE TRANSFER; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN RESPIRATORY SYNCYTIAL VIRUS; LUNG PARENCHYMA; LYMPHOID CELL; MOUSE; NONHUMAN; OVALBUMIN-INDUCED AIRWAY INFLAMMATION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; TH2 CELL; ANIMAL; CELL CULTURE; DISEASE MODEL; HUMAN; HYPERSENSITIVITY; IMMUNOLOGY; INNATE IMMUNITY; LUNG; LYMPHOCYTE; METABOLISM; PHYSIOLOGY; PNEUMOVIRUS; SIGNAL TRANSDUCTION; VIROLOGY;

ALLERGENS; ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNITY, INNATE; INTERLEUKIN-1 RECEPTOR-LIKE 1 PROTEIN; INTERLEUKIN-33; LUNG; LYMPHOCYTES; MICE; OVALBUMIN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 85052924452     PISSN: 1750743X     EISSN: 17507448     Source Type: Journal    
DOI: 10.2217/imt-2018-0059     Document Type: Article

References (33)

1. Wenzel SE. Asthma: defining of the persistent adult phenotypes. Lancet 368(9537), 804-813 (2006).
2. Masoli M, Fabian D, Holt S et al. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59(5), 469-478 (2004).
3. Knudsen TB, Thomsen SF, Nolte H et al. A population-based clinical study of allergic and non-allergic asthma. J. Asthma 46(1), 91-94 (2009).
4. Johnston SL, Pattemore PK, Sanderson G et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 310(6989), 1225-1229 (1995).
5. Atmar RL, Guy E, Guntupalli KK et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch. Intern. Med. 158(22), 2453-2459 (1998).
6. Sigurs N, Gustafsson PM, Bjarnason R et al. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Respir. Crit. Care Med. 171(2), 137-141 (2005).
7. Sigurs N, Bjarnason R, Sigurbergsson F et al. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am. J. Respir. Crit. Care Med. 161(5), 1501-1507 (2000).
8. Stein RT, Sherrill D, Morgan WJ et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 354(9178), 541-545 (1999).
9. Aeffner F, Davis IC. Respiratory syncytial virus reverses airway hyperresponsiveness to methacholine in ovalbumin-sensitized mice. PLoS ONE 7(10), e46660 (2012).
10. Jia Wang, Lingwen Kong, Qingli Luo et al. Dual effects of respiratory syncytial virus infections on airway inflammation by regulation of Th17/Treg responses in ovalbumin-challenged mice. Inflammation 37(6), 1984-2005 (2014).
11. Zhang L, Liu J, Wang E et al. Respiratory syncytial virus protects against the subsequent development of ovalbumin-induced allergic responses by inhibiting Th2-type T cells. J. Med. Virol. 85(1), 149-156 (2013).
12. Walker JA, Barlow JL, McKenzie ANJ. Innate lymphoid cells-how did we miss them? Nat. Rev. Immunol. 13(2), 75-87 (2013).
13. Kabata H, Moro K, Koyasu S et al. Group 2 innate lymphoid cells and asthma. Allergol. Int. 64(3), 227-234 (2015).
14. Barlow JL, Bellosi A, Hardman CS et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J. Allergy Clin. Immunol. 129(1), 191-198 (2012).
15. Klein Wolterink RG, Kleinjan A, van Nimwegen M et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur. J. Immunol. 42(5), 1106-1116 (2012).
16. Reed L, Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27(3), 493-497 (1938).
17. Halim TY, Krauss RH, Sun AC et al. Lung natural helper cells are a critical source of Th2 cell-type cytokines in protease allergen-induced airway inflammation. Immunity 36(3), 451-463 (2012).
18. Bartemes KR, Iijima K, Kobayashi T et al. IL-33-responsive lineage-CD25+ CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J. Immunol. 188(3), 1503-1513 (2012).
19. Chang YJ, Kim HY, Albacker LA et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12(7), 631-638 (2011).
20. Gorski SA, Hahn YS, Braciale TJ. Group 2 innate lymphoid cell production of IL-5 is regulated by NKT cells during influenza virus infection. PLoS Pathog. 9(9), e1003615 (2013).
21. Beamer CA, Girtsman TA, Seaver BP et al. IL-33 mediates multi-walled carbon nanotube (MWCNT)-induced airway hyper-reactivity via the mobilization of innate helper cells in the lung. Nanotoxicology 7(6), 1070-1081 (2013).
22. Shi YH, Shi GC, Wan HY et al. Coexistence of Th1/Th2 and Th17/Treg imbalances in patients with allergic asthma. Chin. Med. J. (Engl). 124(13), 1951-1956 (2011).
23. Carneiro ER, Xavier RA, De Castro MA et al. Electroacupuncture promotes a decrease in inflammatory response associated with Th1/Th2 cytokines, nitric oxide and leukotriene B4 modulation in experimental asthma. Cytokine 50(3), 335-340 (2010).
24. Van Schaik SM, ObotN, Enhorning G et al. Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J. Med. Virol. 62(2), 257-266 (2000).
25. Lloyd CM, Hessel EM. Functions of T cells in asthma: more than just T(H)2 cells. Nat. Rev. Immunol. 10(12), 838-848 (2010).
26. Schmitz J, Owyang A, Oldham E et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23(5), 479-490 (2005).
27. Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: The new kid in the IL-1 family. Nat. Rev. Immunol. 10(2), 103-110 (2010).
28. Mirchandani AS, Salmond RJ, Liew FY. Interleukin-33 and the function of innate lymphoid cells. Trends Immunol. 33(8), 389-396 (2012).
29. Salmond RJ, Mirchandani AS, Besnard AG et al. IL-33 induces innate lymphoid cell-mediated airway inflammation by activating mamMalian target of rapamycin. J. Allergy Clin. Immunol. 130(5), 1159-1166 (2012).
30. Yasuda K, Muto T, Kawagoe T et al. Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematode-infected mice. Proc. Natl Acad. Sci. USA 109(9), 3451-3456 (2012).
31. Molofsky AB, Nussbaum JC, Liang HE et al. Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages. J. Exp. Med. 210(3), 535-549 (2013).
32. Liu B, Kimura Y. Respiratory syncytial virus protects against the subsequent development of Japanese cedar pollen-induced allergic responses. J. Med. Virol. 79(10), 1600-1605 (2007).
33. Saravia J, You D, Shrestha B et al. Respiratory syncytial virus disease is mediated by age-variable IL-33. PLoS Pathog. 11(10), e1005217 (2015).